Categories
- Features
- Foreign News
- General Practice
- Health Management
- Hospital Medicine
- Industrial Relations
- Information Technology
- Interviews
- Medico-Legal
- News
- Obituary
- Planning and Development
- Private Healthcare
- Public Health
- Regulation
- Research and Education
Archives
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- February 2007
Tagcloud
abortion, abuse, acute care, addiction, administration, alcohol, alternative medicine, arthritis, autoimmune disorders, blood, breast cancer, Brendan Drumm, cancer, capacity, cardiovascular disease, CervicalCheck, charity, children, clinical directors, co-location, community care, competence assurance, Competition Authority, complaints, consultants, cosmetic surgery, costs, cross-border, cutbacks, cystic fibrosis, Department of Health, diabetes, disability, Down's syndrome, drugs, e-health, education, elderly, emergency medicine, epilepsy, equity, ESRI, EWTD, fertility, Fitness to Practice, fractures, funding, General Election, genetics, GPs, Hanly report, HIQA, HIV, HPSC, HSE, hse, human tissue, hygiene, IBTS, ICGP, IHCA, IMB, immunity, IMO, imo, industrial action, influenza, INO, insurance, Irish Healthcare Awards, IT, locums, LRC, lung disease, maternity, MAUs, media, medical cards, Medical Council, medical school, medico-legal, men's health, mental health, migraine, MRSA, NCHDs, needle-stick injury, neurology, NHS, Non-EU doctors, North East, NTPF, nurses, nursing home, nutrition, obesity, obstetrics, Ombudsman, out-of-hours, palliative care, pandemic, patient records, PCRS (GMS), pharmaceuticals, pharmacy, politics, practice management, pregnancy, prescribing, primary care, privatisation, quality, radiology, radiotherapy, RCPI, RCSI, reconfiguration, recruitment, regional hospitals, research, savings, screening, sexual assault, sexual health, smoking, sports medicine, stem cells, stroke, suicide, surgery, transplants, transport, tuberculosis, vaccine, Vhi, waiting lists, WHO, women's health, work-life balance
«Previous article | Next article»
Doctors urged to save money
The Medical Council’s new ethical guide has tackled the controversial issue of healthcare resources head on by openly encouraging doctors to prescribe generic drugs.
In a major departure for the Council, the seventh edition of the ‘Guide to Professional Conduct and Ethics for Registered Medical Practitioners’, states that doctors have a ‘duty’ to assist in the efficient and effective use of healthcare resources and to give advice on their appropriate allocation.
“While balancing a duty of care to the individual patient, you should be aware of the wider need to use limited healthcare resources efficiently and responsibly. Such awareness should inform decision making in your clinical practice,” the guide states in Paragraph 49.
Specifically, it informs doctors that they are encouraged to prescribe ‘bio-equivalent generic medicines where they are safe and effective and only commission investigations if they are clinically indicated’.
In its previous guide published in 2004, the Council said doctors had a ‘place’ in helping to ensure the efficient and effective use of resources, but that in exercising indicative drugs budgeting they should be ‘principally concerned with the patient’s best interests’.
Published on the Council’s website, the extended guide runs to more than 60 pages and clarifies a number of matters for doctors and their patients, including issues of consent, confidentiality, end-of-life care, the provision of information to the public, prescribing practices and referral of patients.
However, it has avoided addressing a number of thorny issues, such as assisted human reproduction and stem cell therapy. President Prof Kieran Murphy said the Council was ‘exercised’ by the lack of legislation in this area, and thus was unable to take a position.
“We hope over the term of the remainder of the Council to develop further comprehensive guidelines based on assisted human reproduction,” he stated.
The Council also intends to address the relationship between doctors and commercial enterprises in future guidelines.
While no direct reference is made to stem cells, the guide states that doctors should not participate in ‘creating new forms of life solely for experimental purposes’.
On the controversial subject of abortion, it retains the wording that terminations are illegal except where there is a ‘real and substantial risk’ to the life of the mother.
However, the Council has inserted a clause stating that this exception includes where there is a ‘clear and substantial risk to the life of the mother arising from a threat of suicide’, thus bring the guide into line with the legal position arising from the ‘X’ case.
Posted in Regulation on 20 November 2009
Tags: Medical Council
